KK
ORIC icon

KLP Kapitalforvaltning’s Oric Pharmaceuticals ORIC Stock Holding History

KLP Kapitalforvaltning’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Hold
9,300
– – ﹤0.01% 2078
2026
Q1 		$118K Hold
9,300
– – ﹤0.01% 2006
2025
Q4 		$76.1K Buy
9,300
+2,200
+31% +$25.3K ﹤0.01% 2119
2025
Q3 		$85.2K Buy
+7,100
New +$74.7K ﹤0.01% 2092
2025
Q2 		– Sell
-6,200
Closed -$34.6K – 2246
2025
Q1 		$34.6K Hold
6,200
– – ﹤0.01% 2230
2024
Q4 		$50K Buy
+6,200
New +$56.9K ﹤0.01% 2238

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KLP Kapitalforvaltning's ORIC Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Oric Pharmaceuticals (ORIC) position steady in Q2 2026 at 9,300 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #2078.

KLP Kapitalforvaltning first reported a position in ORIC in Q4 2024 and has held it in 6 quarters since. The position peaked at $118K in Q1 2026. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • KLP Kapitalforvaltning held 9,300 shares of Oric Pharmaceuticals worth $101K as of Q2 2026.
  • KLP Kapitalforvaltning left its Oric Pharmaceuticals share count unchanged in Q2 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #2078 holding.
  • KLP Kapitalforvaltning first reported a position in Oric Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's Oric Pharmaceuticals position peaked at $118K in Q1 2026.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.